Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support further research into levels of prostate cancer amongst black men.

Research is crucial in tackling cancer. The Department spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), with cancer the largest area of spend at more than £121.8 million in 2022/23. NIHR spends more on cancer than any other disease group, reflecting its high priority.

On 19 November 2023, the Government and Prostate Cancer UK announced a £42 million screening trial to find ways of detecting country’s most common male cancer earlier. Prostate Cancer UK is leading the development of the trial with the Government contributing £16 million through the Department.

The TRANSFORM trial will aim to address some of the inequalities that exist in prostate cancer diagnosis today. For example, 1 in 4 black men will develop prostate cancer, double the risk of other men, and often at a younger age. Yet previous research has failed to involve and recruit enough black men and so has not been able to provide evidence needed to diagnose them earlier using a targeted approach. The TRANSFORM trial will ensure that at least 10% of the men who are invited to participate in the trial are black.